4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug
4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug
Read moreFri, 08th Apr 2016 16:17
4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug
Read more(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced progress on activities in its development programme for its lead immuno-oncology single strain 'live biotherapeutic' candidate MRx0518 on Wednesday.
Read moreSMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward
Read more4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress
Read more4D Pharma Joins Landmark Study For Parkinson's Treatment Development
Read more4D Pharma Files US Registration Statement For ADR Programme
Read moreIN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials
Read moreIN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition
Read moreUK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans
Read more4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial
Read moreIN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase
Read moreUK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board
Read moreUK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook
Read more4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"
Read moreUK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech
Read more